UNSPSC 51287007: Glucosulfone sodium

This classification denotes a sulfone anti-infective agent with the molecular formula C24H34N2O18S3.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6RLN7D44F, chemically known as sodium glucosulfone, injection but more generally known as glucosulfone, which bears US NIH Compound Identifier 3481. European Medicines Agency schedules Glucosulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07939MIG. The term GLUCOSULFONE is an International Non-Proprietary Name.

UNSPSC 51287007 Glucosulfone sodium is a Commodity code for a pharmaceutical active ingredient, but recent state and local opportunities do not align with this specific chemical compound — the available solicitations involve finished pharmaceuticals, medical supplies, and pharmacy benefit management programs rather than glucosulfone sodium or its precursors. The Tampa Fire Department procurement (IFB, due March 13, 2026) solicited medical and first aid supplies including respiratory equipment, cardiac monitoring devices, and medical consumables; Seminole County, Florida (IFB, due July 26, 2023) sought naloxone and drug deactivation systems; the Minnesota Multistate Cooperative Purchasing Alliance (RFP, due March 26, 2026) requested generic multi-source pharmaceuticals and OTC products through authorized wholesalers; and the Texas Health and Human Services Commission (RFI, due April 3, 2026) gathered market intelligence on direct-to-manufacturer prescription programs. None of these opportunities center on glucosulfone sodium specifically.

The code shows minimal recent relevant activity aligned to its nominal scope. Issuing bodies include county health departments, cities, state multistate purchasing cooperatives, and state HHS agencies, but the work being procured falls outside glucosulfone sodium's pharmaceutical classification. Geographic spread includes Florida, Texas, Minnesota, and Oregon, but these jurisdictions are not soliciting the specific active ingredient this code describes. A firm pursuing opportunities under this code should verify that posted opportunities explicitly reference glucosulfone sodium or related sulfone compounds before investing in response effort; the current opportunity set suggests the code sees limited state and local demand or is underutilized as a classification for actual procurements in this space.